BindingDB Entry 50015211: Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis.

Small molecule binding data for protein Aurora kinase A, CD63 antigen, Cyclin-dependent kinase-like 2, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytoplasmic tyrosine-protein kinase BMX, Dual specificity mitogen-activated protein kinase kinase 2, Early activation antigen CD69, Mitogen-activated protein kinase kinase kinase 13, Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma, Potassium voltage-gated channel subfamily H member 2, Proto-oncogene tyrosine-protein kinase Src, Sodium channel protein type 5 subunit alpha, Tyrosine-protein kinase BTK, Tyrosine-protein kinase Tec, Tyrosine-protein kinase receptor Tie-1, and Voltage-dependent L-type calcium channel subunit alpha-1C, Uniprot O14965, O43283, O60331, P08684, P08962, P11712, P12931, P35590, P36507, P42680, P51813, Q06187, Q07108, Q12809, Q13936, Q14524, and Q92772